The cannabis business might soon be a lot more lucrative.Shares of Tilray Brands (TLRY +43.89%) surged 65% this past week, according to data provided by S&P Global Market Intelligence. Investors are hopeful that the Trump administration will move to lessen costly regulations on the beleaguered cannabis industry. A highly anticipated executive orderPresident Donald Trump is reportedly contemplating a reclassification of marijuana from a Schedule I drug to a Schedule III drug, according to The Washington Post ...